This protein, also known as CD326, gathers great interest in the recent CRC research as a potential biomarker for tumor-initiating cells and for identifying cancer stem cells within a tumor population, which is significant in CRC early diagnosis [100]. This evidence concerns the gene EPCAM and neoplasm.